References

Citations

1. Davis AJ, Johnson SR (2000, reaffirmed 2005). Premenstrual syndrome. ACOG Practice Bulletin No. 15, pp. 1–9. Washington, DC: American College of Obstetricians and Gynecologists.

2. Dog TL (2001). Integrative treatments for premenstrual syndrome. Alternative Therapies in Health and Medicine, 7(5): 32–39.

3. Halbreich U, et al. (2002). Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstetrics and Gynecology, 100(6): 1219–1229.

4. Grady-Weliky TA (2003). Premenstrual dysphoric disorder. New England Journal of Medicine, 348(5): 433–437.

5. Arias R (2002). Premenstrual syndrome. In DR Mishell et al., eds., Management of Common Problems in Obstetrics and Gynecology, 4th ed., pp. 253–255. Malden, MA: Blackwell.

6. Stanford JB, et al. (2002). Timing intercourse to achieve pregnancy: Current evidence. Obstetrics and Gynecology, 100(6): 1333–1341.

7. Katz VL, et al. (2007). Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder. In LO Eckert, GM Lentz, eds., Comprehensive Gynecology, 5th ed., pp. 901–913. Philadelphia: Mosby Elsevier.

8. Girman A, et al. (2003). An integrative medicine approach to premenstrual syndrome. American Journal of Obstetrics and Gynecology, 188(5, Suppl): S56–S65.

9. Yonkers KA, et al. (2005). Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstetrics and Gynecology, 106(3): 492–501.

10. Kwan I, Onwude JL (2007). Premenstrual syndrome, search date November 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.

11. Berga S (2006). Premenstrual syndrome. In DC Dale, DD Federman, eds., ACP Medicine, section 16, chap. 3. New York: WebMD.

12. Mahady GB et al (2008). United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause, 15(4): 628–638.